The Latest Breaking News from Roth Capital

Upgrades

 

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Roth Capital downgraded its rating of Hecla Mining (NYSE:HL) to Neutral with a price target of $6.50, changing its price target from $6.25 to $6.50. Shares of Hecla Mining are trading up 2.87% over the last 24 hours, at $7.17 per share.

Barrington analyst Vincent Colicchio lowered the price target on Barrett Business Services, Inc. (NASDAQ:BBSI) to $85 from $95 and maintained an Outperform rating on the shares, citing multiple contractions in the peer group average. The company's Q4 earnings beat forecasts, and gross billings increased 13% year over year in Q4, mentions Colicchio. The analyst raised…

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the stock with a Buy rating and a $12 price target.

Marker Therapeutics Inc (NASDAQ: MRKR) shares are trading lower after Roth Capital downgrades the company from Buy t

Roth Capital analyst Richard Baldry upgraded Rimini Street Inc (NASDAQ:RMNI) to Buy from Neutral with an $8 price target, suggesting an upside of 53%. The shares are down 57% versus their highs and trading at only 1.1-times run-rate revenues.  The analyst does believe recent staccato growth results are likely to continue to temper a return…